精神心理科

订阅

MedSci主页 / 所有栏目 / 精神心理科

Lancet Psychiat：儿童焦虑症治疗方法比较

2017-05-18 zhangfan MedSci原创

焦虑症儿童家长参与
关注

家长指导下的认知行为疗法和着重于解决方案的疗法对于儿童焦虑症患者临床效果方面无显著差异，但前者更具有成本效益，应作为一线的儿童焦虑症治疗方法

统计发现，约一半的终生焦虑症患者在12岁前发病且没有接受充分有效的心理治疗。近日研究人员比较了两种简易心理治疗方法--家长指导下的认知行为疗法(CBT)和着重于解决方案的疗法(SFBT)对儿童焦虑的临床效果和成本-效果。

研究在英国进行，5-12岁的焦虑症患儿随机接受一种治疗方法。主要终点是CGI-I评估的临床恢复分数。治疗效果评估在基线、治疗完成以及治疗结束后6个月进行。使用质量修正生命年 (QALYs) 评估治疗成本-效果。

共136名患儿参与，其中CBT组68人，SFBT组68人。研究发现，CBT组中有40人以及SFBT组中有47人的CGI-I得分显著提高，治疗组间无显著差异(CGI-I分数相对差异1.01， 95% CI 0.86-1.19； p=0.95；QALYs平均差异0.006， -0.009 - 0.02； p=0.42)。CBT治疗费用较低(平均差异- 448英镑； 95% CI -9340-37； p=0.070)，考虑到抽样的不确定性，CBT疗法更具成本效益。

研究认为，家长指导下的认知行为疗法和着重于解决方案的疗法对于儿童焦虑症患者临床效果方面无显著差异，但前者更具有成本效益，应作为一线的儿童焦虑症治疗方法。

原始出处：


本文系williamhill asia 医学（MedSci）原创编译整理，转载需授权！

版权声明：
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于williamhill asia 医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章，或“williamhill asia 号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系，williamhill asia 将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1828954, encodeId=cc1c182895440, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Apr 16 09:54:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744281, encodeId=767b1e44281ed, content=<a href='/topic/show?id=d6df58e8151' target=_blank style='color:#2F92EE;'>#方法比较#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58781, encryptionId=d6df58e8151, topicName=方法比较)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f8535318348, createdName=gous, createdTime=Sat Sep 09 09:54:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399216, encodeId=0a6c139921616, content=<a href='/topic/show?id=cac364650c0' target=_blank style='color:#2F92EE;'>#治疗方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64650, encryptionId=cac364650c0, topicName=治疗方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cec2200006, createdName=showtest, createdTime=Sat May 20 04:54:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199866, encodeId=42d2199866a1, content=学习了，谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Fri May 19 07:34:14 CST 2017, time=2017-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199622, encodeId=28cf199622b5, content=学习了，谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu May 18 15:28:32 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199615, encodeId=3b5d19961513, content=学习了，不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhQkEvDREF6S2vZq3ZIpUYjdqicKVoAWaJSGoe8xNvS6o6QpmOlh2AQ7xuUpj8NiaDjJJgjbc7Xj3T6/0, createdBy=1c242047915, createdName=daiyaozu, createdTime=Thu May 18 15:00:24 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199611, encodeId=47e919961131, content=嗯嗯，给了个不错的参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu May 18 14:52:23 CST 2017, time=2017-05-18, status=1, ipAttribution=)]
    2018-04-16 仁医06

    #Lancet#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1828954, encodeId=cc1c182895440, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Apr 16 09:54:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744281, encodeId=767b1e44281ed, content=<a href='/topic/show?id=d6df58e8151' target=_blank style='color:#2F92EE;'>#方法比较#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58781, encryptionId=d6df58e8151, topicName=方法比较)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f8535318348, createdName=gous, createdTime=Sat Sep 09 09:54:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399216, encodeId=0a6c139921616, content=<a href='/topic/show?id=cac364650c0' target=_blank style='color:#2F92EE;'>#治疗方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64650, encryptionId=cac364650c0, topicName=治疗方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cec2200006, createdName=showtest, createdTime=Sat May 20 04:54:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199866, encodeId=42d2199866a1, content=学习了，谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Fri May 19 07:34:14 CST 2017, time=2017-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199622, encodeId=28cf199622b5, content=学习了，谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu May 18 15:28:32 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199615, encodeId=3b5d19961513, content=学习了，不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhQkEvDREF6S2vZq3ZIpUYjdqicKVoAWaJSGoe8xNvS6o6QpmOlh2AQ7xuUpj8NiaDjJJgjbc7Xj3T6/0, createdBy=1c242047915, createdName=daiyaozu, createdTime=Thu May 18 15:00:24 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199611, encodeId=47e919961131, content=嗯嗯，给了个不错的参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu May 18 14:52:23 CST 2017, time=2017-05-18, status=1, ipAttribution=)]
    2017-09-09 gous

    #方法比较#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1828954, encodeId=cc1c182895440, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Apr 16 09:54:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744281, encodeId=767b1e44281ed, content=<a href='/topic/show?id=d6df58e8151' target=_blank style='color:#2F92EE;'>#方法比较#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58781, encryptionId=d6df58e8151, topicName=方法比较)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f8535318348, createdName=gous, createdTime=Sat Sep 09 09:54:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399216, encodeId=0a6c139921616, content=<a href='/topic/show?id=cac364650c0' target=_blank style='color:#2F92EE;'>#治疗方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64650, encryptionId=cac364650c0, topicName=治疗方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cec2200006, createdName=showtest, createdTime=Sat May 20 04:54:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199866, encodeId=42d2199866a1, content=学习了，谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Fri May 19 07:34:14 CST 2017, time=2017-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199622, encodeId=28cf199622b5, content=学习了，谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu May 18 15:28:32 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199615, encodeId=3b5d19961513, content=学习了，不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhQkEvDREF6S2vZq3ZIpUYjdqicKVoAWaJSGoe8xNvS6o6QpmOlh2AQ7xuUpj8NiaDjJJgjbc7Xj3T6/0, createdBy=1c242047915, createdName=daiyaozu, createdTime=Thu May 18 15:00:24 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199611, encodeId=47e919961131, content=嗯嗯，给了个不错的参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu May 18 14:52:23 CST 2017, time=2017-05-18, status=1, ipAttribution=)]
    2017-05-20 showtest

    #治疗方法#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1828954, encodeId=cc1c182895440, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Apr 16 09:54:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744281, encodeId=767b1e44281ed, content=<a href='/topic/show?id=d6df58e8151' target=_blank style='color:#2F92EE;'>#方法比较#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58781, encryptionId=d6df58e8151, topicName=方法比较)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f8535318348, createdName=gous, createdTime=Sat Sep 09 09:54:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399216, encodeId=0a6c139921616, content=<a href='/topic/show?id=cac364650c0' target=_blank style='color:#2F92EE;'>#治疗方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64650, encryptionId=cac364650c0, topicName=治疗方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cec2200006, createdName=showtest, createdTime=Sat May 20 04:54:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199866, encodeId=42d2199866a1, content=学习了，谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Fri May 19 07:34:14 CST 2017, time=2017-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199622, encodeId=28cf199622b5, content=学习了，谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu May 18 15:28:32 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199615, encodeId=3b5d19961513, content=学习了，不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhQkEvDREF6S2vZq3ZIpUYjdqicKVoAWaJSGoe8xNvS6o6QpmOlh2AQ7xuUpj8NiaDjJJgjbc7Xj3T6/0, createdBy=1c242047915, createdName=daiyaozu, createdTime=Thu May 18 15:00:24 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199611, encodeId=47e919961131, content=嗯嗯，给了个不错的参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu May 18 14:52:23 CST 2017, time=2017-05-18, status=1, ipAttribution=)]
    2017-05-19 189****7206

    学习了，谢谢分享。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1828954, encodeId=cc1c182895440, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Apr 16 09:54:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744281, encodeId=767b1e44281ed, content=<a href='/topic/show?id=d6df58e8151' target=_blank style='color:#2F92EE;'>#方法比较#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58781, encryptionId=d6df58e8151, topicName=方法比较)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f8535318348, createdName=gous, createdTime=Sat Sep 09 09:54:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399216, encodeId=0a6c139921616, content=<a href='/topic/show?id=cac364650c0' target=_blank style='color:#2F92EE;'>#治疗方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64650, encryptionId=cac364650c0, topicName=治疗方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cec2200006, createdName=showtest, createdTime=Sat May 20 04:54:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199866, encodeId=42d2199866a1, content=学习了，谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Fri May 19 07:34:14 CST 2017, time=2017-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199622, encodeId=28cf199622b5, content=学习了，谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu May 18 15:28:32 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199615, encodeId=3b5d19961513, content=学习了，不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhQkEvDREF6S2vZq3ZIpUYjdqicKVoAWaJSGoe8xNvS6o6QpmOlh2AQ7xuUpj8NiaDjJJgjbc7Xj3T6/0, createdBy=1c242047915, createdName=daiyaozu, createdTime=Thu May 18 15:00:24 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199611, encodeId=47e919961131, content=嗯嗯，给了个不错的参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu May 18 14:52:23 CST 2017, time=2017-05-18, status=1, ipAttribution=)]
    2017-05-18 1e145228m78(暂无匿称)

    学习了，谢谢作者分享!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1828954, encodeId=cc1c182895440, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Apr 16 09:54:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744281, encodeId=767b1e44281ed, content=<a href='/topic/show?id=d6df58e8151' target=_blank style='color:#2F92EE;'>#方法比较#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58781, encryptionId=d6df58e8151, topicName=方法比较)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f8535318348, createdName=gous, createdTime=Sat Sep 09 09:54:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399216, encodeId=0a6c139921616, content=<a href='/topic/show?id=cac364650c0' target=_blank style='color:#2F92EE;'>#治疗方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64650, encryptionId=cac364650c0, topicName=治疗方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cec2200006, createdName=showtest, createdTime=Sat May 20 04:54:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199866, encodeId=42d2199866a1, content=学习了，谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Fri May 19 07:34:14 CST 2017, time=2017-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199622, encodeId=28cf199622b5, content=学习了，谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu May 18 15:28:32 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199615, encodeId=3b5d19961513, content=学习了，不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhQkEvDREF6S2vZq3ZIpUYjdqicKVoAWaJSGoe8xNvS6o6QpmOlh2AQ7xuUpj8NiaDjJJgjbc7Xj3T6/0, createdBy=1c242047915, createdName=daiyaozu, createdTime=Thu May 18 15:00:24 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199611, encodeId=47e919961131, content=嗯嗯，给了个不错的参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu May 18 14:52:23 CST 2017, time=2017-05-18, status=1, ipAttribution=)]
    2017-05-18 daiyaozu

    学习了，不错

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1828954, encodeId=cc1c182895440, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Apr 16 09:54:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744281, encodeId=767b1e44281ed, content=<a href='/topic/show?id=d6df58e8151' target=_blank style='color:#2F92EE;'>#方法比较#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58781, encryptionId=d6df58e8151, topicName=方法比较)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f8535318348, createdName=gous, createdTime=Sat Sep 09 09:54:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399216, encodeId=0a6c139921616, content=<a href='/topic/show?id=cac364650c0' target=_blank style='color:#2F92EE;'>#治疗方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64650, encryptionId=cac364650c0, topicName=治疗方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cec2200006, createdName=showtest, createdTime=Sat May 20 04:54:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199866, encodeId=42d2199866a1, content=学习了，谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Fri May 19 07:34:14 CST 2017, time=2017-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199622, encodeId=28cf199622b5, content=学习了，谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu May 18 15:28:32 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199615, encodeId=3b5d19961513, content=学习了，不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhQkEvDREF6S2vZq3ZIpUYjdqicKVoAWaJSGoe8xNvS6o6QpmOlh2AQ7xuUpj8NiaDjJJgjbc7Xj3T6/0, createdBy=1c242047915, createdName=daiyaozu, createdTime=Thu May 18 15:00:24 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199611, encodeId=47e919961131, content=嗯嗯，给了个不错的参考, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu May 18 14:52:23 CST 2017, time=2017-05-18, status=1, ipAttribution=)]
    2017-05-18 131****2916

    嗯嗯，给了个不错的参考

    0

相关威廉亚洲官网

NAT COMMUN：天然大麻素在焦虑症中起关键作用

美国数百万人存在压力相关性情绪和焦虑症。一项最新研究对这些疾病背后的神经生物学机制进行研究后发现，控制一种激活大麻素受体的分子可以减少焦虑症状。

一文了解：近期焦虑症相关研究进展

焦虑症，又称为焦虑性神经症，是神经症这一大类疾病中最常见的一种，以焦虑情绪体验为主要特征。目前病因尚不明确，可能与遗传因素、个性特点、认知过程、不良生活事件、生化、躯体疾病等均有关系。本文小编为大家汇总相关研究进展，与大家分享。【1】Diabetes Care：2型糖尿病合并抑郁症和焦虑症状对死亡率风险有何影响？ 近日，糖尿病领域权威杂志Diabetes Care发表了一篇研究文章，

焦虑症或许会导致患癌男性过早死亡

全球大约14个人中就有1人在一生的某个特定时间里就会收到焦虑症的困扰，那些遭受焦虑症困扰的患者都会经历机体损伤、残疾等状况，同时还会处于高风险的药物滥用以及自杀状况之中；尽管存在相当大的风险，但科学家们对焦虑症的研究还远远滞后于对其它常见精神健康问题的研究，甚至很多患者都并不知道自己是焦虑症患者。 在很多时候，甚至过了十几年，焦虑症患者才会去找医生寻求治疗方法，然而这么长的时间往往会给患

PLoS One：“工作狂”容易出现强迫症、焦虑症?

一项新的研究表明，与具有较好的工作、生活平衡能力的人群相比，工作狂可能容易产生精神健康障碍。 该项研究的作者表示，这些精神健康障碍可能包括：焦虑、注意力缺陷多动障碍(ADHD)，强迫症(OCD)和抑郁症等。 在该项研究中，研究这么难对15,000多名挪威人的相关信息进行了评估，研究结果表明，“极端的工作状态，可能会引起人们更深层次的精神问题，”该研究报告的主要作者 Cecili

Eur Psychiatry:焦虑患者，警惕卒中发生

背景：焦虑症是世界上最常见的心理健康问题。然而，关于焦虑症与卒中风险之间的相关性的证据有限。本系统回顾和荟萃分析总结现有的焦虑症和卒中风险之间相关性的证据。方法: 检索PubMed、EMBASE、PsycINFO、Scopus、和Web of Science数据库中，2016年6月之前，研究焦虑症和卒中风险的队列研究。使用标准化标准评估研究质量。进行荟萃分析，获得焦虑症患者发生卒中风险的汇总估计。

J Am Acad Child Psy：儿童精神障碍是否会增加物质依赖性疾病？

使用荟萃分析评估儿童期精神障碍（即注意力缺陷/多动障碍[ADHD]，对抗性障碍/行为障碍[ODD / CD]，焦虑障碍和抑郁症）发生药物性相关疾病的潜在风险。